- Global Pharma News & Resources

Javara And Wake Forest Baptist Medical Center Sign Letter Of Intent To Design An Operating Model To Advance Patient Access To Clinical Trials

WINSTON-SALEM, N.C., Sept. 25, 2018 /PRNewswire/ -- Javara Inc., and Wake Forest Baptist Medical Center (WFBMC) announce they have signed a letter of intent to design a fully integrated operating model that will expand integration of industry-sponsored clinical trials to patients for whom WFBMC serves, making clinical trials more accessible.

Javara is pleased to offer WFBMC the additional resources needed to advance clinical research offerings to the patient community; mobilizing patient-centric clinical trials to serve the needs and interests of the patients while shaping the future of medicine and healthcare. Over the next several months, leaders of WFBMC and Javara will work to define and launch a comprehensive solution and implementation strategy to more effectively engage patients in clinical research. Advancing clinical research offerings across WFBMC will not only provide opportunities for state-of-the art clinical care but also serve their aspirations to define the state-of-the art clinical care of tomorrow through a robust offering of clinical trials. "Wake Forest Baptist is committed to providing leading access to industry, NIH and other advanced clinical trials for truly exceptional and unparalleled care to our patients.  Our relationship with Javara is a key step to expanding the impact of that commitment," said Terry G. Williams, Executive Vice President and Chief Strategy Officer, WFBMC.

Javara is committed to bringing forth a more relevant clinical trial experience for value-oriented healthcare systems and their patients, allowing for improved access to cutting edge therapies and generating better outcomes within patient-centered care.  Jennifer J. Byrne, CEO of Javara, commented, "This is a milestone moment in healthcare and the clinical trial enterprise with Wake Forest Baptist Health as a leading Academic Medical Center deeply committing to transform healthcare delivery while advancing clinical trial access to their patient community.  We look forward to navigating a new journey together in the mission to better integrate clinical research as an option within the continuum of care for patients." 

Integration of clinical research within the clinical care delivery of an academic medical center like WFBMC stands to revolutionize the way clinical trials are conducted, leading to positive outcomes for patients, healthcare and the drug development enterprise.  Clinical trial operations as of a result of this collaboration are expected to launch first quarter 2019.

Media Relations

Wake Forest Baptist Medical Center
Paula Faria, Assistant Vice President of Media Relations

Linda McCarty, General Counsel & Privacy Officer

Editor Details

Related Links

Last Updated: 27-Sep-2018